Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis

Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began in late 2019. More recently, there have been sporadic case reports on development of Miller-Fisher Syndrome , a rare variant of Guillain-Barré Syndrome in COVID...

Full description

Bibliographic Details
Main Authors: Souheil Zayet, Hajer Zahra, Nabil Belfeki, Timothée Klopfenstein, Beate Hagenkötter
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Infectious Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772431X22000053
_version_ 1827373913260163072
author Souheil Zayet
Hajer Zahra
Nabil Belfeki
Timothée Klopfenstein
Beate Hagenkötter
author_facet Souheil Zayet
Hajer Zahra
Nabil Belfeki
Timothée Klopfenstein
Beate Hagenkötter
author_sort Souheil Zayet
collection DOAJ
description Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began in late 2019. More recently, there have been sporadic case reports on development of Miller-Fisher Syndrome , a rare variant of Guillain-Barré Syndrome in COVID-19 patients. Case report: We reported herein the case of a French young women presenting with ophtalmoplegia, cerebellar ataxia, and universal areflexia following a bariatric surgery (sleeve gastrectomy). A concomitant COVID-19 diagnosis was retained based on microbiological testing. The patient was successfully treated after high-dose intravenous thiamine, but areflexia persisted. Underlying COVID-19 related Miller-Fisher Syndrome was established on physical examination and confirmed by pathologic neurophysiological findings and elevated level of phosphorylated neurofilament heavy chain protein in cerebrospinal fluid analysis. Conclusions: Guillain-Barré Syndrome and its variants after SARS-CoV-2 infection are extremely rare. The measurement of phosphorylated neurofilament heavy chain protein should be considered as an easy tool to detect an early affection of the peripheral nervous system.
first_indexed 2024-03-08T11:24:44Z
format Article
id doaj.art-7066e5d465d74e368fe4fa7521226b7d
institution Directory Open Access Journal
issn 2772-431X
language English
last_indexed 2024-03-08T11:24:44Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Infectious Medicine
spelling doaj.art-7066e5d465d74e368fe4fa7521226b7d2024-01-26T05:35:53ZengElsevierInfectious Medicine2772-431X2022-06-0112140142Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosisSouheil Zayet0Hajer Zahra1Nabil Belfeki2Timothée Klopfenstein3Beate Hagenkötter4Infectious Diseases Department, Nord Franche-Comté Hospital, France; Corresponding author.Diabetology Department, Nord Franche-Comté Hospital, FranceInternal Medicine Department, Groupe Hospitalier Sud Ile de France, Melun, FranceInfectious Diseases Department, Nord Franche-Comté Hospital, FranceNeurology Department, Nord Franche-Comté Hospital, FranceBackground: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began in late 2019. More recently, there have been sporadic case reports on development of Miller-Fisher Syndrome , a rare variant of Guillain-Barré Syndrome in COVID-19 patients. Case report: We reported herein the case of a French young women presenting with ophtalmoplegia, cerebellar ataxia, and universal areflexia following a bariatric surgery (sleeve gastrectomy). A concomitant COVID-19 diagnosis was retained based on microbiological testing. The patient was successfully treated after high-dose intravenous thiamine, but areflexia persisted. Underlying COVID-19 related Miller-Fisher Syndrome was established on physical examination and confirmed by pathologic neurophysiological findings and elevated level of phosphorylated neurofilament heavy chain protein in cerebrospinal fluid analysis. Conclusions: Guillain-Barré Syndrome and its variants after SARS-CoV-2 infection are extremely rare. The measurement of phosphorylated neurofilament heavy chain protein should be considered as an easy tool to detect an early affection of the peripheral nervous system.http://www.sciencedirect.com/science/article/pii/S2772431X22000053COVID-19Miller-fisher syndromeWernicke encephalopathyBariatric surgeryPhosphorylated neurofilament heavy chain Protein
spellingShingle Souheil Zayet
Hajer Zahra
Nabil Belfeki
Timothée Klopfenstein
Beate Hagenkötter
Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
Infectious Medicine
COVID-19
Miller-fisher syndrome
Wernicke encephalopathy
Bariatric surgery
Phosphorylated neurofilament heavy chain Protein
title Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
title_full Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
title_fullStr Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
title_full_unstemmed Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
title_short Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
title_sort atypical miller fisher syndrome after covid 19 and sleeve gastrectomy contribution of neurochemical markers to early diagnosis
topic COVID-19
Miller-fisher syndrome
Wernicke encephalopathy
Bariatric surgery
Phosphorylated neurofilament heavy chain Protein
url http://www.sciencedirect.com/science/article/pii/S2772431X22000053
work_keys_str_mv AT souheilzayet atypicalmillerfishersyndromeaftercovid19andsleevegastrectomycontributionofneurochemicalmarkerstoearlydiagnosis
AT hajerzahra atypicalmillerfishersyndromeaftercovid19andsleevegastrectomycontributionofneurochemicalmarkerstoearlydiagnosis
AT nabilbelfeki atypicalmillerfishersyndromeaftercovid19andsleevegastrectomycontributionofneurochemicalmarkerstoearlydiagnosis
AT timotheeklopfenstein atypicalmillerfishersyndromeaftercovid19andsleevegastrectomycontributionofneurochemicalmarkerstoearlydiagnosis
AT beatehagenkotter atypicalmillerfishersyndromeaftercovid19andsleevegastrectomycontributionofneurochemicalmarkerstoearlydiagnosis